Celgene Corporation and Norvatis Pharmaceuticals Sues Actavis South Atlantic

  • April 19, 2011

Celgene Corporation and Norvatis Pharmaceuticals files suit against Actavis South Atlantic over six patents related to ADHD medicine.  4/15, District of New Jersey, 2:2011cv02162.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×